Diagnosis Year
Select the diagnosis year first. The STORE workspace uses it to identify the applicable standards cycle and to flag year-sensitive guidance.
STORE Standards Context
Case Eligibility & Reportability
CoC-required cases
Use STORE to determine which tumors must be accessioned, abstracted, followed, and submitted for CoC purposes. State/central registry requirements may be broader.
Reportable by agreement
A cancer committee or central registry may request collection of tumors not otherwise required by the CoC. Follow the requesting standard setter for the extent of abstraction and follow-up.
Open State Reportability module →Ambiguous Terminology
Terms that constitute a diagnosis
Do not constitute a diagnosis without additional information
Ambiguous-Term Checker
Cytology Exception
Class of Case
Complete the fields to generate a suggested class.
Date of First Contact
Analytic case
Use the date the patient became analytic—when the case first qualifies as Class of Case 00–22.
Nonanalytic case
Use the date the nonanalytic status begins under the standard setter that requires the case.
Autopsy / pathology-only
Autopsy-only uses date of death. For state-required pathology-only Class 43, use specimen collection date unless later updated when the patient receives first-course treatment at the facility.
Cancer Identification
Staging Principles
Use the site module
J’Onco Mentor disease modules contain diagnosis-year-aware AJCC schema routing and TNM input controls where applicable.
Open disease modules →Clinical vs pathologic context
Keep clinical, pathologic, and posttherapy classifications distinct. Use the current AJCC system required for the selected diagnosis year and schema.
NCDB / AJCC resources ↗Treatment Coding
Surgery
First course surgery, site-specific surgery codes, margins, lymph node surgery, and reason for no surgery.
Radiation
Phase-specific treatment volume, modality, planning technique, dose, fractions, and treatment sequence.
Open Radiation Guide →Systemic / Other
Chemotherapy, hormone therapy, immunotherapy, hematologic transplant/endocrine procedures, other treatment, and palliative care.
Follow-Up / Recurrence
Local recurrence
Recurrence in the initial primary organ.
Regional recurrence
Recurrence in an adjacent organ or lymph nodes draining the organ.
Distant recurrence
Recurrence in a location beyond regional.
Secondary Diagnoses
STORE Secondary Diagnosis #1–10
Capture existing/preexisting medical conditions, factors influencing health status, and complications for treatment of this cancer using ICD-10-CM values according to the applicable STORE instructions.
J’Onco ICD-10-CM tool
Search codes and build the ten secondary-diagnosis slots in the dedicated module.
Open ICD-10-CM / Secondary DX →2027 Changes — High-Impact Registry Items
| Area | 2027 impact |
|---|---|
| Class of Case | Codes 11 and 12 are no longer available beginning with diagnosis year 2027; prior 11/12 situations route to 13/14 under the revised reporting-facility framework. |
| Date of First Contact | Guidance was revised/clarified, including the outside-specimen scenario and the point at which a nonanalytic case becomes analytic. |
| Secondary Diagnoses | Instructions were updated, including broader description language and additional source guidance. |
| Method of Detection — Breast | Instructions were revised and clarified for 2027; the field remains diagnosis-year dependent. |
| Recurrence / Follow-Up | Trocar recurrence wording was removed; follow-up language now explicitly references the 15-year endpoint for Disease Follow-up/First Recurrence-Progression and Vital Status. |
| Source links | STORE 2027 added links to resources throughout the manual. |